IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: April 2024

Volume 9 | Issue 4

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Study the Effect of Indian Gentian, Genoprotective Agent in Type 2 Diabetes Mellitus Patients
Authors Name: Priyanka Sharma , Dr. Ravinder Pal Singh
Unique Id: IJSDR1906013
Published In: Volume 4 Issue 6, June-2019
Abstract: The present study was undertaken to study the effect of Indian Gentian, a herb, as a genoprotective agent in type 2 diabetes mellitus (T2DM) patients. For this, a total of 52 T2DM patients were investigated, of which 38 received 500 mg - 1 g Indian Gentian thrice daily escalated over three months (Group 1). The remaining 14 patients were not given the herb (Group 2). Fifteen age and sex matched non diabetic healthy volunteers served as controls (Group 3). All three groups were studied for DNA damage by comet assay and Sister Chromatid Exchanges (SCEs); Group 1 was also investigated for protein oxidation. Paired and unpaired t tests were performed at 95% confidence interval. Results of comet assay and SCE studies revealed that in Group 1, post Indian Gentian treatment, normal cell population increased, whereas moderately damaged, highly damaged and apoptotic cell population and SCE decreased as compared to Group 1 (pre-treatment patients) and Group 2 (without treatment patients). In comet assay, statistically significant difference between Group 1 (post-treatment patients) and Group 3 (controls) suggested that the herb was able to decrease the DNA damage but not as low as non-diabetic healthy controls. On the other hand, SCE analysis showed that the herb can reduce such exchanges to as low as the controls. In protein oxidation assay, no significant difference was found between the pre- and post-treatment T2DM patients of Group 1. The present study therefore indicated that overall Indian Gentian may have a significant effect on reducing DNA damage and attenuating SCEs in T2DM patients.
Keywords: Indian Gentian, T2DM, Comet Assay, SCEs, Protein Oxidation,DNA etc
Cite Article: "Study the Effect of Indian Gentian, Genoprotective Agent in Type 2 Diabetes Mellitus Patients", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.4, Issue 6, page no.53 - 58, June-2019, Available :http://www.ijsdr.org/papers/IJSDR1906013.pdf
Downloads: 000337071
Publication Details: Published Paper ID: IJSDR1906013
Registration ID:190640
Published In: Volume 4 Issue 6, June-2019
DOI (Digital Object Identifier):
Page No: 53 - 58
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner